# A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber

> **NCT04176185** · PHASE3 · TERMINATED · sponsor: **ALK-Abelló A/S** · enrollment: 80 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Sublingual allergy immunological tablet
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04176185
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-04
- **Primary completion:** 2019-12-17
- **Final completion:** 2022-01-19
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** COVID-19
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04176185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04176185, "A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04176185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*